AI assistant
ICO Group Limited — Capital/Financing Update 2016
Oct 24, 2016
49938_rns_2016-10-24_4c1e2eb2-3fe9-4a42-9cdf-057fa0bbfb86.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
==> picture [58 x 23] intentionally omitted <==
==> picture [58 x 24] intentionally omitted <==
==> picture [215 x 71] intentionally omitted <==
(Incorporated in Bermuda with limited liability)
(Stock Code : 630)
UPDATE ON FINANCIAL INFORMATION
This announcement is made pursuant to Rule 13.09 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (“ Listing Rules ”) and the Inside Information Provisions (as defined in the Listing Rules).
The board (“ Board ”) of directors (“ Directors ”, each a “ Director ”) of AMCO United Holding Limited (“ Company ” and together with its subsidiaries, the “ Group ”) wishes to inform the shareholders of the Company and potential investors that, based on information currently available, the revenue attributable to the Group’s business segments in relation to the manufacture and sale of medical devices products (“ Medical Device Business ”) and the manufacture and sale of plastic moulding products (“ Plastic Moulding Business ”) for the year ending 31 December 2016 (“ FY2016 ”) are expected to decrease significantly as compared with the revenue attributable to the same segments for the year ended 31 December 2015 (“ FY2015 ”) and this may result in the overall revenue of the Group’s continuing operation for FY2016 as a whole. For FY2015, the revenue of the Medical Device Business amounted to approximately HK$54.3 million, representing approximately 75% of the Group’s revenue for such period, and for the six months ended 30 June 2016, the revenue attributable to the Medical Device Business amounted to approximately HK$24.9 million, representing approximately 45.8% of the Group’s revenue for its continuing operation for such period. The Plastic Moulding Business recorded a revenue of approximately HK$16.6 million for FY2015, representing approximately 23% of the Group’s revenue for such period, and recorded a revenue of approximately HK$1.9 million for the six months ended 30 June 2016, representing approximately 4% of the Group’s revenue for its continuing operation for such period.
- For identification purposes only
1
As FY2016 has not yet ended, the information contained in this announcement is only based on the preliminary assessment by the management of the Company by information currently available to the Group (including the unaudited management accounts of the Group for the eight months ended 31 August 2016 and the confirmed orders on hand) and is not based on any figure or information which has been audited or reviewed by the Company’s auditor. Details of the Group’s financial information and performance for FY2016 will be disclosed when the Group’s final results for FY2016 are announced.
Shareholders of the Company and potential investors should exercise caution when dealing in the shares of the Company.
On behalf of the Board AMCO United Holding Limited YIP Wai Lun, Alvin Chairman and Managing Director
Hong Kong, 24 October 2016
As at the date of this announcement, Mr. Yip Wai Lun, Alvin, Mr. Cheng Kin Chor, Mr. Leung Kelvin Ming Yuen, Mr. Zhang Hengxin, Mr. Peng Shiyuan and Mr. Jia Minghui are the executive Directors; and Mr. Wong Siu Ki, Mr. Chan Ngai Sang Kenny and Mr. Li Kwok Fat are the independent non-executive Directors.
2